Albert Lamontagne

762 total citations
6 papers, 314 citations indexed

About

Albert Lamontagne is a scholar working on Neurology, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, Albert Lamontagne has authored 6 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 2 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Physiology. Recurrent topics in Albert Lamontagne's work include Botulinum Toxin and Related Neurological Disorders (2 papers), Amyotrophic Lateral Sclerosis Research (1 paper) and interferon and immune responses (1 paper). Albert Lamontagne is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (2 papers), Amyotrophic Lateral Sclerosis Research (1 paper) and interferon and immune responses (1 paper). Albert Lamontagne collaborates with scholars based in Canada, United States and Denmark. Albert Lamontagne's co-authors include Fritz Buchthal, Jacques Lamarche, Ziad Nasreddine, Virginia M.‐Y. Lee, Daniel H. Geschwind, Bruce L. Miller, Kirk C. Wilhelmsen, Victoria Zhukareva, Lorraine N. Clark and J.P. Bouchard and has published in prestigious journals such as Annals of Neurology, PLoS Biology and Critical Care Medicine.

In The Last Decade

Albert Lamontagne

6 papers receiving 293 citations

Peers

Albert Lamontagne

NEURO

PHYSI

MB

CMN

NEURO

G. Galimberti Italy

Amanda Newell United States

Graham Warner United Kingdom

Walter E. Kozachuk United States

G.J. Zipfel United States

Sara Ortega‐Cubero Spain

C. Oberwittler Germany

P. Vinall United States

Takamura Nagasaka Japan

Hiroyuki Sumikura Japan

G. Galimberti Italy

Albert Lamontagne

152 ×0.9

NEURO

143 ×0.9

PHYSI

63 ×0.8

MB

38 ×0.6

CMN

30 ×0.5

NEURO

Citations per year, relative to Albert Lamontagne Albert Lamontagne (= 1×) peers G. Galimberti

Countries citing papers authored by Albert Lamontagne

Since Specialization

Citations

This map shows the geographic impact of Albert Lamontagne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Lamontagne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Lamontagne more than expected).

Fields of papers citing papers by Albert Lamontagne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Lamontagne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Lamontagne. The network helps show where Albert Lamontagne may publish in the future.

Co-authorship network of co-authors of Albert Lamontagne

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Lamontagne. A scholar is included among the top collaborators of Albert Lamontagne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Lamontagne. Albert Lamontagne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Rheault, François, Guillaume Theaud, Frédéric Laberge, et al.. (2021). Modern Technology in Multi-Shell Diffusion MRI Reveals Diffuse White Matter Changes in Young Adults With Relapsing-Remitting Multiple Sclerosis. Frontiers in Neuroscience. 15. 665017–665017. 6 indexed citations

2.

Gharagozloo, Marjan, Shaimaa Mahmoud, Camille Simard, et al.. (2019). NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunity. PLoS Biology. 17(9). e3000451–e3000451. 25 indexed citations

3.

Masse, Marie-Hélène, Frédérick D’Aragon, Charles St-Arnaud, et al.. (2018). Early Evidence of Sepsis-Associated Hyperperfusion—A Study of Cerebral Blood Flow Measured With MRI Arterial Spin Labeling in Critically Ill Septic Patients and Control Subjects*. Critical Care Medicine. 46(7). e663–e669. 13 indexed citations

4.

Nasreddine, Ziad, Lorraine N. Clark, Jacques Lamarche, et al.. (1999). From genotype to phenotype: A clinical, pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation. Annals of Neurology. 45(6). 704–715. 100 indexed citations

5.

Peyronnard, J.M., et al.. (1976). Nerve Conduction Studies and Electromyography in Friedreich's Ataxia. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 3(4). 313–317. 35 indexed citations

6.

Lamontagne, Albert & Fritz Buchthal. (1970). Electrophysiological studies in diabetic neuropathy. Journal of Neurology Neurosurgery & Psychiatry. 33(4). 442–452. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact